The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International Report

Authors: Belpomme, Dominique, George L. Carlo, Philippe Irigaray, David O. Carpenter, Lennart Hardell, Michael Kundi, Igor Belyaev, Magda Havas, Franz Adlkofer, Gunnar Heuser, Anthony B. Miller, Daniela Caccamo, Chiara De Luca, Lebrecht von Klitzing, Martin L. Pall, Priyanka Bandara, Yael Stein, Cindy Sage, Morando Soffritti, Devra Davis, Joel M. Moskowitz, S. M.J. Mortazavi, Martha R. Herbert, Hanns Moshammer, Gerard Ledoigt, Robert Turner, Anthony Tweedale, Pilar Muñoz-Calero, Iris Udasin, Tarmo Koppel, Ernesto Burgio, André Vander Vorst

Year: 2021

Category: Health Sciences

Journal: International Journal of Molecular Sciences

DOI: 10.3390/ijms22147321

URL: https://www.mdpi.com/1422-0067/22/14/7321

Abstract

Overview

Clinical research is pivotal in objectively identifying and characterizing diseases through clinical observations and biological and radiological findings. This step is crucial for establishing objective diagnostic criteria and treatments.

Challenges and Methodologies

The abstract outlines significant issues in the research methodologies particularly related to "provocation tests" used in studying Electrohypersensitivity (EHS). These tests, which focus on hypersensitivity to man-made electromagnetic fields (EMF), are critiqued for not investigating the causal origins of EHS and relying on flawed methodologies without adequate objective definitions or endpoints.

Findings

  • The negative results of EMF-related provocation tests do not rule out EMF exposure as a symptomatic trigger in EHS patients.
  • There is no evidence suggesting that EHS symptoms or the condition itself are caused by psychosomatic or nocebo effects.

Conclusion

This international consensus report advocates for the recognition of EHS as a distinct neuropathological disorder and calls for its inclusion in the WHO International Classification of Diseases.

← Back to Stats